You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

Article metrics

Article menu

Download PDFPDF

XML
Basic tumor immunology
Short report
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

 

Online download statistics by month:

Online download statistics by month: June 2020 to August 2025

AbstractFullPdf
Jun 2020229230112
Jul 2020727230
Aug 2020545412
Sep 2020747437
Oct 2020535317
Nov 2020616126
Dec 2020878730
Jan 2021989827
Feb 2021646517
Mar 202110510537
Apr 2021898925
May 2021616121
Jun 2021666647
Jul 2021828220
Aug 2021666618
Sep 2021494916
Oct 2021656533
Nov 2021777738
Dec 2021545516
Jan 2022556022
Feb 2022303714
Mar 2022495221
Apr 2022526019
May 2022767831
Jun 2022708125
Jul 2022484912
Aug 2022475228
Sep 2022656933
Oct 2022737314
Nov 2022637026
Dec 2022505115
Jan 2023525412
Feb 2023909118
Mar 2023667111
Apr 2023495531
May 2023465014
Jun 2023475111
Jul 2023737525
Aug 2023979739
Sep 2023636320
Oct 2023616519
Nov 2023737612
Dec 2023303012
Jan 2024363812
Feb 2024525722
Mar 2024777871
Apr 2024788127
May 2024777839
Jun 2024605923
Jul 2024757723
Aug 2024464516
Sep 2024556030
Oct 2024656522
Nov 2024666821
Dec 2024626219
Jan 2025545517
Feb 202510711014
Mar 2025666626
Apr 2025505118
May 2025626429
Jun 2025333319
Jul 2025110
Aug 2025110
Total405441681511